BAG3 Attenuates Ischemia-Induced Skeletal Muscle Necroptosis in Diabetic Experimental Peripheral Artery Disease
Abstract
:1. Introduction
2. Results
2.1. Ischemia Enhances BAG3 Expression in Primary Human Skeletal Muscle Cells (HSMC)
2.2. Mice with Diabetes Have Decreased BAG3 Expression in Ischemic Limbs
2.3. In Vitro, BAG3 Knockdown Decreases Cell Viability, Reduces Autophagy and Enhances Necroptosis in HSMCs
2.4. In Vivo, Ischemic Skeletal Muscle in Diabetic Mice Shows Decreased Autophagy and Increased Necroptosis
2.5. BAG3 Overexpression Improves Autophagy and Decreases Necroptosis in Ischemic GA Muscles in Diabetes
2.6. BAG3 Overexpression Improves Limb Necrosis Score, Perfusion Recovery, Muscle Function and Muscle Regeneration in Diabetic PAD
3. Discussion
4. Materials and Methods
4.1. Animals
4.2. In Vivo Adenoviral Injection
4.3. Cell Culture and Simulated Ischemia
4.4. In Vitro Plasmid Transfection
4.5. Cell Morphology and Viability Assay
4.6. TaqMan qPCR
4.7. HLI Surgery, Perfusion Recovery and Limb Necrosis Score
4.8. Western Blots
4.9. Western Blots Quantification
4.10. Muscle Contractile Function
4.11. Immunohistochemistry
4.12. Statistical Analysis
Supplementary Materials
Author Contributions
Funding
Institutional Review Board Statement
Informed Consent Statement
Data Availability Statement
Acknowledgments
Conflicts of Interest
References
- Dhaliwal, G.; Mukherjee, D. Peripheral arterial disease: Epidemiology, natural history, diagnosis and treatment. Int. J. Angiol. 2007, 16, 36–44. [Google Scholar] [CrossRef] [PubMed]
- Fowkes, F.G.; Rudan, D.; Rudan, I.; Aboyans, V.; Denenberg, J.O.; McDermott, M.M.; Norman, P.E.; Sampson, U.K.A.; Williams, L.J.; Mensah, G.A.; et al. Comparison of global estimates of prevalence and risk factors for peripheral artery disease in 2000 and 2010: A systematic review and analysis. Lancet 2013, 382, 1329–1340. [Google Scholar] [CrossRef]
- Hirsch, A.T.; Duval, S. The global pandemic of peripheral artery disease. Lancet 2013, 382, 1312–1314. [Google Scholar] [CrossRef]
- Jude, E.B.; Eleftheriadou, I.; Tentolouris, N. Peripheral arterial disease in diabetes—A review. Diabet. Med. 2010, 27, 4–14. [Google Scholar] [CrossRef]
- Paneni, F.; Beckman, J.A.; Creager, M.A.; Cosentino, F. Diabetes and vascular disease: Pathophysiology, clinical consequences, and medical therapy: Part I. Eur. Heart J. 2013, 34, 2436–2443. [Google Scholar] [CrossRef]
- Thiruvoipati, T.; Kielhorn, C.E.; Armstrong, E.J. Peripheral artery disease in patients with diabetes: Epidemiology, mechanisms, and outcomes. World J. Diabetes 2015, 6, 961–969. [Google Scholar] [CrossRef]
- Haltmayer, M.; Mueller, T.; Horvath, W.; Luft, C.; Poelz, W.; Haidinger, D. Impact of atherosclerotic risk factors on the anatomical distribution of peripheral arterial disease. Int. Angiol. 2001, 20, 200–207. [Google Scholar]
- Jude, E.B.; Oyibo, S.O.; Chalmers, N.; Boulton, A.J. Peripheral arterial disease in diabetic and nondiabetic patients: A comparison of severity and outcome. Diabetes Care 2001, 24, 1433–1437. [Google Scholar] [CrossRef]
- Marso, S.P.; Hiatt, W.R. Peripheral arterial disease in patients with diabetes. J. Am. Coll. Cardiol. 2006, 47, 921–929. [Google Scholar] [CrossRef]
- Melton, L.J., 3rd; Macken, K.M.; Palumbo, P.J.; Elveback, L.R. Incidence and prevalence of clinical peripheral vascular disease in a population-based cohort of diabetic patients. Diabetes Care 1980, 3, 650–654. [Google Scholar] [CrossRef]
- Dokun, A.O.; Chen, L.; Lanjewar, S.S.; Lye, R.J.; Annex, B.H. Glycaemic control improves perfusion recovery and VEGFR2 protein expression in diabetic mice following experimental PAD. Cardiovasc. Res. 2014, 101, 364–372. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Chen, L.; Okeke, E.; Ayalew, D.; Wang, D.; Shahid, L.; Dokun, A.O. Modulation of miR29a improves impaired post-ischemic angiogenesis in hyperglycemia. Exp. Biol. Med. 2017, 242, 1432–1443. [Google Scholar] [CrossRef] [PubMed]
- Lamin, V.; Verry, J.; Eigner-Bybee, I.; Fuqua, J.D.; Wong, T.; Lira, V.A.; Dokun, A.O. Modulation of miR-29a and ADAM12 Reduces Post-Ischemic Skeletal Muscle Injury and Improves Perfusion Recovery and Skeletal Muscle Function in a Mouse Model of Type 2 Diabetes and Peripheral Artery Disease. Int. J. Mol. Sci. 2021, 23, 429. [Google Scholar] [CrossRef]
- Bhat, H.K.; Hiatt, W.R.; Hoppel, C.L.; Brass, E.P. Skeletal muscle mitochondrial DNA injury in patients with unilateral peripheral arterial disease. Circulation 1999, 99, 807–812. [Google Scholar] [CrossRef] [PubMed]
- Brass, E.P.; Hiatt, W.R. Acquired skeletal muscle metabolic myopathy in atherosclerotic peripheral arterial disease. Vasc. Med. 2000, 5, 55–59. [Google Scholar] [CrossRef] [PubMed]
- Van Weel, V.; Deckers, M.M.; Grimbergen, J.M.; van Leuven, K.J.; Lardenoye, J.H.; Schlingemann, R.O.; van Nieuw Amerongen, G.P.; van Bockel, J.H.; van Hinsbergh, V.W.M.; Quax, P.H.A.; et al. Vascular endothelial growth factor overexpression in ischemic skeletal muscle enhances myoglobin expression in vivo. Circ. Res. 2004, 95, 58–66. [Google Scholar] [CrossRef]
- Rissanen, T.T.; Vajanto, I.; Hiltunen, M.O.; Rutanen, J.; Kettunen, M.I.; Niemi, M.; Leppänen, P.; Turunen, M.P.; Markkanen, J.E.; Arve, K.; et al. Expression of vascular endothelial growth factor and vascular endothelial growth factor receptor-2 (KDR/Flk-1) in ischemic skeletal muscle and its regeneration. Am. J. Pathol. 2002, 160, 1393–1403. [Google Scholar] [CrossRef]
- McClung, J.M.; McCord, T.J.; Keum, S.; Johnson, S.; Annex, B.H.; Marchuk, D.A.; Kontos, C.D. Skeletal muscle-specific genetic determinants contribute to the differential strain-dependent effects of hindlimb ischemia in mice. Am. J. Pathol. 2012, 180, 2156–2169. [Google Scholar] [CrossRef]
- Ryan, T.E.; Schmidt, C.A.; Green, T.D.; Brown, D.A.; Neufer, P.D.; McClung, J.M. Mitochondrial Regulation of the Muscle Microenvironment in Critical Limb Ischemia. Front. Physiol. 2015, 6, 336. [Google Scholar] [CrossRef]
- Dokun, A.O.; Chen, L.; Okutsu, M.; Farber, C.R.; Hazarika, S.; Jones, W.S.; Craig, D.; Marchuk, D.A.; Lye, R.J.; Shah, S.H.; et al. ADAM12: A genetic modifier of preclinical peripheral arterial disease. Am. J. Physiol. Heart Circ. Physiol. 2015, 309, H790–H803. [Google Scholar] [CrossRef]
- Md, A.O.D.; Keum, S.; Hazarika, S.; Li, Y.; Lamonte, G.M.; Wheeler, F.; Marchuk, D.; Annex, B.H. A quantitative trait locus (LSq-1) on mouse chromosome 7 is linked to the absence of tissue loss after surgical Hindlimb ischemia. Circulation 2008, 117, 1207–1215. [Google Scholar]
- McClung, J.M.; McCord, T.J.; Ryan, T.E.; Schmidt, C.A.; Green, T.D.; Southerland, K.W.; Reinardy, J.L.; Mueller, S.B.; Venkatraman, T.N.; Lascola, C.D.; et al. BAG3 (Bcl-2-Associated Athanogene-3) Coding Variant in Mice Determines Susceptibility to Ischemic Limb Muscle Myopathy by Directing Autophagy. Circulation 2017, 136, 281–296. [Google Scholar] [CrossRef] [PubMed]
- Okeke, E.; Dokun, A.O. Role of genetics in peripheral arterial disease outcomes; significance of limb-salvage quantitative locus-1 genes. Exp. Biol. Med. 2018, 243, 190–197. [Google Scholar] [CrossRef] [PubMed]
- Kirk, J.A.; Cheung, J.Y.; Feldman, A.M. Therapeutic targeting of BAG3: Considering its complexity in cancer and heart disease. J. Clin. Investig. 2021, 131, e149415. [Google Scholar] [CrossRef]
- Homma, S.; Iwasaki, M.; Shelton, G.D.; Engvall, E.; Reed, J.C.; Takayama, S. BAG3 deficiency results in fulminant myopathy and early lethality. Am. J. Pathol. 2006, 169, 761–773. [Google Scholar] [CrossRef]
- Selcen, D.; Muntoni, F.; Burton, B.K.; Pegoraro, E.; Sewry, C.; Bite, A.V.; Engel, A.G. Mutation in BAG3 causes severe dominant childhood muscular dystrophy. Ann. Neurol. 2009, 65, 83–89. [Google Scholar] [CrossRef]
- Carra, S.; Seguin, S.J.; Lambert, H.; Landry, J. HspB8 chaperone activity toward poly(Q)-containing proteins depends on its association with Bag3, a stimulator of macroautophagy. J. Biol. Chem. 2008, 283, 1437–1444. [Google Scholar] [CrossRef]
- Carra, S.; Seguin, S.J.; Landry, J. HspB8 and Bag3: A new chaperone complex targeting misfolded proteins to macroautophagy. Autophagy 2008, 4, 237–239. [Google Scholar] [CrossRef]
- Fuchs, M.; Poirier, D.J.; Seguin, S.J.; Lambert, H.; Carra, S.; Charette, S.J.; Landry, J. Identification of the key structural motifs involved in HspB8/HspB6-Bag3 interaction. Biochem. J. 2009, 425, 245–255. [Google Scholar] [CrossRef]
- Gamerdinger, M.; Carra, S.; Behl, C. Emerging roles of molecular chaperones and co-chaperones in selective autophagy: Focus on BAG proteins. J. Mol. Med. 2011, 89, 1175–1182. [Google Scholar] [CrossRef]
- Gamerdinger, M.; Hajieva, P.; Kaya, A.M.; Wolfrum, U.; Hartl, F.U.; Behl, C. Protein quality control during aging involves recruitment of the macroautophagy pathway by BAG3. EMBO J. 2009, 28, 889–901. [Google Scholar] [CrossRef]
- Sciorati, C.; Rigamonti, E.; Manfredi, A.A.; Rovere-Querini, P. Cell death, clearance and immunity in the skeletal muscle. Cell Death Differ. 2016, 23, 927–937. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Wu, M.Y.; Yiang, G.T.; Liao, W.T.; Tsai, A.P.; Cheng, Y.L.; Cheng, P.W.; Li, C.-Y.; Li, C.J. Current Mechanistic Concepts in Ischemia and Reperfusion Injury. Cell. Physiol. Biochem. 2018, 46, 1650–1667. [Google Scholar] [CrossRef] [PubMed]
- Morgan, J.E.; Prola, A.; Mariot, V.; Pini, V.; Meng, J.; Hourde, C.; Dumonceaux, J.; Conti, F.; Relaix, F.; Authier, F.J.; et al. Necroptosis mediates myofibre death in dystrophin-deficient mice. Nat. Commun. 2018, 9, 3655. [Google Scholar] [CrossRef] [PubMed]
- Lim, J.; Park, H.; Heisler, J.; Maculins, T.; Roose-Girma, M.; Xu, M.; McKenzie, B.; Campagne, M.V.L.; Newton, K.; Murthy, A. Autophagy regulates inflammatory programmed cell death via turnover of RHIM-domain proteins. eLife 2019, 8, e44452. [Google Scholar] [CrossRef] [PubMed]
- Ying, A.F.; Tang, T.Y.; Jin, A.; Chong, T.T.; Hausenloy, D.J.; Koh, W.P. Diabetes and other vascular risk factors in association with the risk of lower extremity amputation in chronic limb-threatening ischemia: A prospective cohort study. Cardiovasc. Diabetol. 2022, 21, 7. [Google Scholar] [CrossRef] [PubMed]
- Barnes, J.A.; Eid, M.A.; Creager, M.A.; Goodney, P.P. Epidemiology and Risk of Amputation in Patients with Diabetes Mellitus and Peripheral Artery Disease. Arterioscler. Thromb. Vasc. Biol. 2020, 40, 1808–1817. [Google Scholar] [CrossRef]
- Rosati, A.; Graziano, V.; De Laurenzi, V.; Pascale, M.; Turco, M.C. BAG3: A multifaceted protein that regulates major cell pathways. Cell Death Dis. 2011, 2, e141. [Google Scholar] [CrossRef]
- Falco, A.; Festa, M.; Basile, A.; Rosati, A.; Pascale, M.; Florenzano, F.; Nori, S.L.; Nicolin, V.; Di Benedetto, M.; Vecchione, M.L.; et al. BAG3 controls angiogenesis through regulation of ERK phosphorylation. Oncogene 2012, 31, 5153–5161. [Google Scholar] [CrossRef]
- Zhang, J.; He, Z.; Xiao, W.; Na, Q.; Wu, T.; Su, K.; Cui, X. Overexpression of BAG3 Attenuates Hypoxia-Induced Cardiomyocyte Apoptosis by Inducing Autophagy. Cell Physiol. Biochem. 2016, 39, 491–500. [Google Scholar] [CrossRef]
- Xiao, H.; Tong, R.; Cheng, S.; Lv, Z.; Ding, C.; Du, C.; Xie, H.; Zhou, L.; Wu, J.; Zheng, S. BAG3 and HIF-1 alpha coexpression detected by immunohistochemistry correlated with prognosis in hepatocellular carcinoma after liver transplantation. BioMed Res. Int. 2014, 2014, 516518. [Google Scholar] [CrossRef]
- Alleboina, S.; Ayalew, D.; Peravali, R.; Chen, L.; Wong, T.; Dokun, A.O. Dual specificity phosphatase 5 regulates perfusion recovery in experimental peripheral artery disease. Vasc. Med. 2019, 24, 395–404. [Google Scholar] [CrossRef] [PubMed]
- Gilda, J.E.; Gomes, A.V. Stain-Free total protein staining is a superior loading control to beta-actin for Western blots. Anal. Biochem. 2013, 440, 186–188. [Google Scholar] [CrossRef] [PubMed]
- Fuqua, J.D.; Mere, C.P.; Kronemberger, A.; Blomme, J.; Bae, D.; Turner, K.D.; Harris, M.P.; Scudese, E.; Edwards, M.; Ebert, S.M.; et al. ULK2 is essential for degradation of ubiquitinated protein aggregates and homeostasis in skeletal muscle. FASEB J. 2019, 33, 11735–11745. [Google Scholar] [CrossRef] [PubMed]
- Folker, E.S.; Baylies, M.K. Nuclear positioning in muscle development and disease. Front. Physiol. 2013, 4, 363. [Google Scholar] [CrossRef] [Green Version]
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations. |
© 2022 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Mani, A.M.; Dhanabalan, K.; Lamin, V.; Wong, T.; Singh, M.V.; Dokun, A.O. BAG3 Attenuates Ischemia-Induced Skeletal Muscle Necroptosis in Diabetic Experimental Peripheral Artery Disease. Int. J. Mol. Sci. 2022, 23, 10715. https://doi.org/10.3390/ijms231810715
Mani AM, Dhanabalan K, Lamin V, Wong T, Singh MV, Dokun AO. BAG3 Attenuates Ischemia-Induced Skeletal Muscle Necroptosis in Diabetic Experimental Peripheral Artery Disease. International Journal of Molecular Sciences. 2022; 23(18):10715. https://doi.org/10.3390/ijms231810715
Chicago/Turabian StyleMani, Arul M., Karthik Dhanabalan, Victor Lamin, Thomas Wong, Madhu V. Singh, and Ayotunde O. Dokun. 2022. "BAG3 Attenuates Ischemia-Induced Skeletal Muscle Necroptosis in Diabetic Experimental Peripheral Artery Disease" International Journal of Molecular Sciences 23, no. 18: 10715. https://doi.org/10.3390/ijms231810715